SCHEMBL2914994

SCHEMBL2914994

COc1ccc(CC2(C(C(=O)NC3CCCCC3)C3CCCCC3)Nc3cc(F)c(F)cc3N2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
EPHX1 P07099 1/20 0.48
CTSD P07339 5/20 0.47
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
TSHR P16473 1/20 0.43
FKBP1A P62942 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
GAA P10253 2/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
POLB P06746 1/20 0.42
RECQL P46063 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2914853 0.92 MEN1 (0.46) MEN1KMT2AEPHX1CTSDNPC1
SCHEMBL2912844 0.86 LMNA (0.49) MEN1KMT2ANPC1RAB9ANPSR1
SCHEMBL2909783 0.83 LMNA (0.46) MEN1KMT2ANPC1RAB9ATSHR
SCHEMBL3648607 0.83 MEN1 (0.49) MEN1KMT2AEPHX1CTSDNPC1
SCHEMBL2912657 0.81 EPHX2 (0.51) MEN1KMT2AEPHX1NPC1RAB9A
SCHEMBL3645044 0.80 ALDH1A1 (0.41) MEN1KMT2AEPHX1CTSDNPC1
SCHEMBL3650741 0.79 MAPT (0.47) MEN1KMT2AEPHX1NPC1RAB9A
SCHEMBL2907076 0.79 LMNA (0.47) MEN1KMT2ANPC1RAB9ANPSR1
SCHEMBL3651170 0.78 NPC1 (0.40) MEN1KMT2ANPC1RAB9ATSHR
SCHEMBL2909849 0.78 NPC1 (0.46) MEN1KMT2AEPHX1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed